Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Jun 2, 2015
Insider Transaction Report
Form 4
Getman Daniel P
Director
Transactions
- Award
Director Stock Option (right to buy)
2015-05-29+20,000→ 110,000 totalExercise: $16.23Exp: 2025-05-29→ Class A Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Vesting commences June 29, 2015 in 12 equal monthly installments.